Post-streptococcal glomerulonephritis overview: Difference between revisions

Jump to navigation Jump to search
Line 56: Line 56:


==Other Diagnostic Studies==
==Other Diagnostic Studies==
Renal biopsy is routinely not done to diagnose [[post-streptococcal glomerulonephritis]]. There are the indications for biopsy include persistent [[proteinuria]] of more than 6 months, persistent microscopic [[hematuria]] more than 18 months, decreasing [[GFR]] after 4 weeks, and persistent [[hypocomplementemia]] after 6 weeks.


==Treatment==
==Treatment==

Revision as of 15:30, 14 June 2018

Post-streptococcal glomerulonephritis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Post-streptococcal glomerulonephritis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Post-streptococcal glomerulonephritis overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Post-streptococcal glomerulonephritis overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Post-streptococcal glomerulonephritis overview

CDC on Post-streptococcal glomerulonephritis overview

Post-streptococcal glomerulonephritis overview in the news

Blogs on Post-streptococcal glomerulonephritis overview

Directions to Hospitals Treating Post-streptococcal glomerulonephritis

Risk calculators and risk factors for Post-streptococcal glomerulonephritis overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]; Associate Editor(s)-in-Chief:

Overview

Historical Perspective

Classification

There is no established system for the classification of post-streptococcal glomerulonephritis.

Pathophysiology

Causes

Differentiating Xyz from Other Diseases

Epidemiology and Demographics

Risk Factors

Common risk factors in the development of post-streptococcal glomerulonephritis include streptococcal throat infection and impetigo. Less common risk factors are household infection with the nephritogenic strain of group A streptococcal.

Screening

There is insufficient evidence to recommend routine screening for post-streptococcal glomerulonephritis.

Natural History, Complications, and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Patients with post-streptococcal glomerulonephritis may have a positive history of streptococcal throat infection and streptococcal skin infection. Common symptoms of post-streptococcal glomerulonephritis include dark urine, oliguria, periorbital edema and hypertension. Less common symptoms of post-streptococcal glomerulonephritis include general malaise, weakness, anorexia, nausea and vomiting.

Physical Examination

Laboratory Findings

Electrocardiogram

There are no ECG findings associated with post-streptococcal glomerulonephritis.

X-ray

Echocardiography and Ultrasound

CT scan

There are no CT scan findings associated with post-streptococcal glomerulonephritis.

MRI

There are no MRI findings associated with post-streptococcal glomerulonephritis.

Other Imaging Findings

There are no other imaging findings associated with post-streptococcal glomerulonephritis.

Other Diagnostic Studies

Renal biopsy is routinely not done to diagnose post-streptococcal glomerulonephritis. There are the indications for biopsy include persistent proteinuria of more than 6 months, persistent microscopic hematuria more than 18 months, decreasing GFR after 4 weeks, and persistent hypocomplementemia after 6 weeks.

Treatment

Medical Therapy

The mainstay of treatment is pharmacotherapy, however dietary therapy is useful for controlling edema and hypertension. Dietary therapy includes low salt, protein intake, and water restriction. If the streptococcal infection is still present, it should be treated with antibiotics. To control severe hypertension, labetalol is usually used, For mild to moderate hypertension, furosemide is used. For rapidly progressive crescentic acute post-streptococcal glomerulonephritis, methylprednisolone is preferred.

Surgery

Surgical intervention is not recommended for the management of post-streptococcal glomerulonephritis.

Primary Prevention

Effective measures for the primary prevention of post-streptococcal glomerulonephritis include improving hand hygiene, better housing, prevent overcrowding, treatment of an infected patient within 24 hours with antibiotics and prevent close contact. A 26-valent vaccine is recommended for children to prevent post-streptococcal glomerulonephritis.

Secondary Prevention

Post-streptococcal glomerulonephritis is resolved completely, however, effective measures for the secondary prevention of post-streptococcal glomerulonephritis include compliant with anti-hypertensive medication and follow up with the nephrologist

References

Template:WH Template:WS